Hyperspectral imaging: A non-invasive method of imaging melanoma lesions in a patient with stage IV melanoma, being treated with a RAF inhibitor

Cancer Biology and Therapy

Volumn 12, Issue 4, 2011, Pages 326-334

  Dicker, David T ^a   Kahn, Nadia ^b   Flaherty, Keith T ^c   Lerner, Jeremy ^d   El Deiry, Wafik S ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^d LightForm Inc   (United States)

Author keywords

Hyperspectral imaging; Melanoma; Multispectral imaging; Non invasive spectral imaging; Spectral library

Indexed keywords

B RAF KINASE INHIBITOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CASE REPORT; COURSE EVALUATION; DIFFUSE REFLECTANCE SPECTROSCOPY; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MACROSCOPIC PRISM AND REFLECTANCE IMAGING SPECTROSCOPY; MALE; MELANOMA; NON INVASIVE MEASUREMENT; SKIN EXAMINATION;

DIAGNOSTIC IMAGING; HUMANS; MELANOMA; NEOPLASM STAGING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS B-RAF; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN; SKIN NEOPLASMS; SPECTRUM ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860389250     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.4.17142     Document Type: Article

References (16)

1. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Verweij J., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92:205-16. PMID:10655437 doi:10.1093/jnci/92. 3.205
2. Anderson R.R., Parrish JA The optics of human skin J Invest Dermatol 1981; 77:13-9. PMID:7252245 doi:10.1111/1523-1747.ep12479191
3. Zonios G., Dimou A Modeling diffuse reflectance from semi-infinite turbid media: application to the study of skin optical properties Opt Express 2006; 14:8661-74. PMID:19529247 doi:10.1364/OE.14.008661
4. Tumeh P.C., Lerner J.M., Dicker D.T., El-Deiry WS Differentiation of vascular and non-vascular spectral signatures using in vivo hyperspectral radiometric imaging Cancer Biol Ther 2007; 6:447-53. PMID:17387267 doi:10.4161/cbt.6.3.4019
5. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949-54. PMID:12068308 doi:10.1038/nature00766
6. Flaherty K.T., McArthur G BRAF a Target in Melanoma, Implications for solid tumor drug development Cancer 2010; 116:4902-13. PMID:20629085 doi:10.1002/cncr.25261
7. Flaherty K.T., Puzanov I., Kim K.B., Ribas A., McArthur G.A., Sosman J.A., et al. Inhibition of mutated, activated braf in metastatic melanoma. N Engl J Med 2010; 363:809-19. PMID:20818844 doi:10.1056/NEJMoa1002011
8. Dicker D.T., Lerner J., Van Belle P., Barth S.F., Guerry D. 4th, Herlyn M., et al. Differentiation of normal skin and melanoma using high resolution hyperspectral imaging. Cancer Biol Ther 2006; 5:1033-8. PMID:16931902 doi:10.4161/cbt.5.8.3261
9. Zonios G., Dimou A., Bassukas I., Galaris D., Tsolakidis A., Kaxiras, E. Melanin adsorption spectroscopy: New method for noninvasive skin investigation and melanoma detection. J Biomed Optics 2008; 13: 014017 doi:10.1117/1.2844710.
10. Zonios G., Dimou A., Carrara M., Marchesini R In vivo optical properties of melanocytic skin lesions: common nevi, dysplastic nevi, and malignant melanoma Photochem Photobiol 2010; 86:236-40. PMID:19845538 doi:10.1111/j.1751- 1097.2009.00630.x
11. Marchesini R., Bono A., Carrara M. In vivo characterization of melanin in melanocytic lesions: Spectrographic study on 1671 pigmentd skin lesions. J Biomed Optics 2009;14:040027 doi:10.1117/1.3080140.
12. D'Alessandro B., Dhawan AP Depth-dependent hemoglobin analysis from multispectral images IEEE Trans Biomed Eng 2010; 57:2568-71. PMID:20639166 doi:10.1109/TBME.2010.2059025
13. Tomatis S., Carrara M., Bono A., Bartoli C., Lualdi M., Tragni G., et al. Automated melanoma detection with a novel multispectral imaging systen: rresults of a prospective study. Phys Med Biol 2005; 50:1675-87. PMID:15815089 doi:10.1088/0031-9155/50/8/004
14. Dhawan A.P., D'Alessandro B., Patwardhan S., Mullani N. Multispectral optical imaging of skin-lesions for detection of malignant melanomas. Ann Int Conf IEEE EMBS (2009) 5352-5355
15. Martin M.E., Wabuyele M.B., Chen K., Kasili P., Panjehpour M., Phan M., et al. Development of an advanced hyperspectral imaging (his) system with applications for cancer detection. Ann Biomeg Eng 2006; 34:1061-1068doi:10.1007/ s10439-006-9121-9. (Pubitemid 43954338)
16. Hatzivassiliou G., Song K., Yen I., Brandhuber B.J., Anderson D.J., Alvarado R., et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 2010; 464:431-5. PMID:20130576 doi:10.1038/nature08833.